Physician profile
Eleanor Yip
NPI 1407632508
$1,459.01
in general payments reported to CMS, 2019-2025
14 companies · $874 in 2025
The $874 reported for 2025 was more than what 86% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $585 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,459.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $418.88 | 2024-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $214.43 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $185.09 | 2024-2025 | Verquvo, Winrevair, Capvaxive |
| Pfizer INC. | $108.64 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $89.85 | 2024-2025 | Amvuttra, Onpattro |
| Scpharmaceuticals INC. | $86.42 | 2024-2025 | |
| Bridgebio Pharma, INC. | $74.82 | 2025 | Attruby |
| Daiichi Sankyo INC. | $61.00 | 2024 | Injectafer |
| Kestra Medical Technology Services, INC. | $53.91 | 2025 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $46.13 | 2025 | |
| Ancora Heart, INC. | $39.27 | 2024 | Accucinch |
| Cvrx, INC. | $35.57 | 2025 | Barostim Neo System |
| Astrazeneca Pharmaceuticals Lp | $26.91 | 2025 | Farxiga |
| Esperion Therapeutics, INC. | $18.09 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eleanor Yip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.